| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | 118,750 | 20 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics, Inc. | 20 Jun 2025 | 1 | $0 | 4 | CHIEF FINANCIAL OFFICER | 24 Jun 2025, 16:18 |
| RAPT | RAPT Therapeutics, Inc. | 30 Jan 2025 | 1 | $0 | 4 | CHIEF FINANCIAL OFFICER | 03 Feb 2025, 18:24 |
| RAPT | RAPT Therapeutics, Inc. | 13 Nov 2024 | 10 | $0 | 4 | CHIEF FINANCIAL OFFICER | 15 Nov 2024, 20:00 |
| RAPT | RAPT Therapeutics, Inc. | 31 Jan 2024 | 1 | $0 | 4 | CHIEF FINANCIAL OFFICER | 01 Feb 2024, 20:45 |
| RAPT | RAPT Therapeutics, Inc. | 31 Jan 2023 | 1 | $0 | 4 | Chief Financial Officer | 02 Feb 2023, 17:23 |
| RAPT | RAPT Therapeutics, Inc. | 10 May 2022 | 1 | +$52,650 | 4 | Chief Financial Officer | 12 May 2022, 17:00 |
| RAPT | RAPT Therapeutics, Inc. | 28 Jan 2022 | 1 | $0 | 4 | Chief Financial Officer | 14 Feb 2022, 18:14 |